SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-007457
Filing Date
2021-02-03
Accepted
2021-02-03 18:29:54
Documents
2
Period of Report
2021-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7104
2 POA DOCUMENT poa.txt EX-24.3_959802 3141
  Complete submission text file 0001209191-21-007457.txt   11604
Mailing Address C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016
Business Address
Poukalov Konstantin (Reporting) CIK: 0001678736 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39971 | Film No.: 21587846

Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations